In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

Michael Rubin on Building Fanatics Into a Billion-Dollar Empire Videos cannot play due to a network issue. Please check your Internet connection and try again.

In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

Giants’ Jaxson Dart on board for Michael Rubin’s bigger and better Fanatics Fest sequel Giants rookie QB Jaxson Dart will be on hand this weekend at Fanatics Fest at the Javits Center.

In this exclusive interview, Michael Rubin — founder and CEO of Fanatics — shares the remarkable journey behind building one of the most powerful companies in sports and e-commerce. He tells ...

The Fanatics CEO joins Boardroom’s Rich Kleiman to explain why acting quickly after mistakes is helping the company consistently stay relevant.

The Fanatics CEO sits down with Boardroom’s Rich Kleiman to discuss the driving force behind the company’s inaugural Fanatics Fest last year and what to expect from this year’s event.

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its 2025-26 budget plans.

A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees.

CagriSema shows mild-to-moderate side effects in trials Researcher sees benefit to additional weight-loss options Novo Nordisk plans regulatory filing for CagriSema in early 2026 June 22 (Reuters ...